Financials MeiraGTx Holdings plc

Equities

MGTX

KYG596651029

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
4.8 USD +1.91% Intraday chart for MeiraGTx Holdings plc -5.70% -31.62%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 732.2 657.3 1,055 316.1 446.5 308.7 - -
Enterprise Value (EV) 1 732.2 657.3 1,055 316.1 446.5 308.7 308.7 308.7
P/E ratio -12.1 x -9.83 x -13.2 x -2.27 x -4.71 x -2.72 x 3.61 x 7.11 x
Yield - - - - - - - -
Capitalization / Revenue 55.1 x 42.2 x 28 x 19.9 x 31.9 x 5.54 x 1.13 x 0.75 x
EV / Revenue 55.1 x 42.2 x 28 x 19.9 x 31.9 x 5.54 x 1.13 x 0.75 x
EV / EBITDA - -11.3 x -16.2 x -2.94 x -3.62 x -3.27 x 5.47 x -
EV / FCF 66,172,702 x -7,742,368 x -18,551,192 x -2,677,187 x - - - -
FCF Yield 0% -0% -0% -0% - - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 36,572 43,412 44,449 48,477 63,597 64,307 - -
Reference price 2 20.02 15.14 23.74 6.520 7.020 4.800 4.800 4.800
Announcement Date 3/11/20 3/11/21 3/10/22 3/14/23 3/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 13.29 15.56 37.7 15.92 14.02 55.77 273 409
EBITDA 1 - -58.38 -65.32 -107.6 -123.3 -94.37 56.47 -
EBIT 1 -58.27 -62.55 -73.19 -116.4 -137.1 -124.4 134.6 52.36
Operating Margin -438.37% -401.94% -194.14% -730.87% -977.82% -222.99% 49.33% 12.8%
Earnings before Tax (EBT) 1 -54.75 -57.99 -79.56 -129.6 -84.03 -126.2 132.9 48.06
Net income 1 -54.75 -57.99 -79.56 -129.6 -84.03 -126.2 132.9 48.06
Net margin -411.87% -372.63% -211.03% -814.16% -599.46% -226.25% 48.68% 11.75%
EPS 2 -1.650 -1.540 -1.800 -2.870 -1.490 -1.762 1.330 0.6750
Free Cash Flow 11.06 -84.89 -56.88 -118.1 - - - -
FCF margin 83.24% -545.47% -150.87% -741.59% - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 3/11/20 3/11/21 3/10/22 3/14/23 3/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 6.947 21.04 5.633 10.76 4.816 -5.288 3.334 3.54 5.103 2.04 9.688 9.688 9.688 10.62 9.946
EBITDA - - - - - - - - - - - - - - -
EBIT 1 -22.55 -8.124 -28.73 -23.76 -22.81 -41.06 -31.76 -28.78 -32.76 -43.75 -31.36 -32.54 -34.21 -34.45 17.05
Operating Margin -324.63% -38.61% -510.1% -220.82% -473.59% 776.38% -952.61% -813.14% -642.01% -2,144.8% -323.74% -335.87% -353.16% -324.24% 171.44%
Earnings before Tax (EBT) 1 -25.94 -9.912 -31.04 -33.97 -37.28 -27.31 -30.36 -29.58 -44.3 20.22 -31.94 -33.61 -35.29 -36.02 16.48
Net income 1 -25.94 -9.912 -31.04 -33.97 -37.28 -27.31 -30.36 -29.58 -44.3 20.22 -31.94 -33.61 -35.29 -36.02 16.48
Net margin -373.47% -47.1% -551.13% -315.76% -774.17% 516.51% -910.74% -835.62% -868.06% 990.93% -329.67% -346.96% -364.25% -339.05% 165.66%
EPS 2 -0.5900 -0.2200 -0.7000 -0.7600 -0.8300 -0.5800 -0.6200 -0.5300 -0.7400 0.4200 -0.5050 -0.4950 -0.5250 -0.5150 0.2400
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/10/21 3/10/22 5/12/22 8/11/22 11/10/22 3/14/23 5/11/23 8/10/23 11/14/23 3/14/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 11.1 -84.9 -56.9 -118 - - - -
ROE (net income / shareholders' equity) - -27% -37.5% -85.5% -65.7% -100% - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share 2 - -1.700 -0.2400 -1.620 -1.870 0.0100 1.820 -
Capex 8.98 20.9 46.4 45 - - - -
Capex / Sales 67.56% 134.44% 122.94% 282.43% - - - -
Announcement Date 3/11/20 3/11/21 3/10/22 3/14/23 3/14/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.8 USD
Average target price
21.6 USD
Spread / Average Target
+350.00%
Consensus
  1. Stock Market
  2. Equities
  3. MGTX Stock
  4. Financials MeiraGTx Holdings plc